Ontario’s government announced a reduction in eligibility for out‑of‑country drug funding, which blocks a Stage 4 melanoma patient from receiving treatment in the United States. The change comes after a court ruling granted the patient the right to seek therapy abroad.
The province’s health program had previously covered certain out‑of‑country drug treatments. Following the legal challenge, the rules governing such coverage are being tightened.